These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 22262002)

  • 21. The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial.
    Grey A; Bolland M; Fenwick S; Horne A; Gamble G; Drury PL; Reid IR
    Eur J Endocrinol; 2014 Feb; 170(2):255-62. PubMed ID: 24217934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
    Bilezikian JP; Josse RG; Eastell R; Lewiecki EM; Miller CG; Wooddell M; Northcutt AR; Kravitz BG; Paul G; Cobitz AR; Nino AJ; Fitzpatrick LA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1519-28. PubMed ID: 23450056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.
    Palermo A; D'Onofrio L; Eastell R; Schwartz AV; Pozzilli P; Napoli N
    Osteoporos Int; 2015 Aug; 26(8):2073-89. PubMed ID: 25910746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone disorders associated with diabetes mellitus and its treatments.
    Cortet B; Lucas S; Legroux-Gerot I; Penel G; Chauveau C; Paccou J
    Joint Bone Spine; 2019 May; 86(3):315-320. PubMed ID: 30098423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and fractures: an overshadowed association.
    Khazai NB; Beck GR; Umpierrez GE
    Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):435-45. PubMed ID: 19779334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.
    Lee HS; Hwang JS
    Curr Diab Rep; 2020 Nov; 20(12):78. PubMed ID: 33247351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.
    Alba M; Xie J; Fung A; Desai M
    Curr Med Res Opin; 2016 Aug; 32(8):1375-85. PubMed ID: 27046479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
    Wolverton D; Blair MM
    Am J Health Syst Pharm; 2017 Aug; 74(15):1143-1151. PubMed ID: 28743778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and fragility fractures - a burgeoning epidemic?
    Epstein S; LeRoith D
    Bone; 2008 Jul; 43(1):3-6. PubMed ID: 18486581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diabetic paradox: Bone mineral density and fracture in type 2 diabetes.
    Botella Martínez S; Varo Cenarruzabeitia N; Escalada San Martin J; Calleja Canelas A
    Endocrinol Nutr; 2016 Nov; 63(9):495-501. PubMed ID: 27481443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hip geometry in diabetic women: implications for fracture risk.
    Garg R; Chen Z; Beck T; Cauley JA; Wu G; Nelson D; Lewis B; LaCroix A; LeBoff MS
    Metabolism; 2012 Dec; 61(12):1756-62. PubMed ID: 22726843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes medications and bone.
    Grey A
    Curr Osteoporos Rep; 2015 Feb; 13(1):35-40. PubMed ID: 25433437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 diabetes mellitus and fracture risk.
    Dede AD; Tournis S; Dontas I; Trovas G
    Metabolism; 2014 Dec; 63(12):1480-90. PubMed ID: 25284729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone damage in type 2 diabetes mellitus.
    Carnevale V; Romagnoli E; D'Erasmo L; D'Erasmo E
    Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1151-7. PubMed ID: 25150773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.
    Chiodini I; Gaudio A; Palermo A; Napoli N; Vescini F; Falchetti A; Merlotti D; Eller-Vainicher C; Carnevale V; Scillitani A; Pugliese G; Rendina D; Salcuni A; Bertoldo F; Gonnelli S; Nuti R; Toscano V; Triggiani V; Cenci S; Gennari L
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2210-2233. PubMed ID: 34059385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes and the skeleton: new insights into sweet bones.
    Shanbhogue VV; Mitchell DM; Rosen CJ; Bouxsein ML
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):159-73. PubMed ID: 26365605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
    Yaturu S; Bryant B; Jain SK
    Diabetes Care; 2007 Jun; 30(6):1574-6. PubMed ID: 17363747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.